Two Sigma Investments’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.04M | Buy |
406,913
+144,009
| +55% | +$2.49M | 0.01% | 999 |
|
|
2025
Q1 | $5.75M | Buy |
+262,904
| New | +$5.75M | 0.01% | 1012 |
|
|
2024
Q4 | – | Sell |
-58,783
| Closed | -$1.7M | – | 3125 |
|
|
2024
Q3 | $1.7M | Buy |
58,783
+31,237
| +113% | +$901K | ﹤0.01% | 1719 |
|
|
2024
Q2 | $1.06M | Buy |
+27,546
| New | +$1.06M | ﹤0.01% | 1884 |
|
|
2022
Q4 | – | Sell |
-113,472
| Closed | -$7.75M | – | 2727 |
|
|
2022
Q3 | $7.75M | Buy |
+113,472
| New | +$7.75M | 0.03% | 565 |
|
|
2021
Q4 | – | Sell |
-362,204
| Closed | -$11.9M | – | 2560 |
|
|
2021
Q3 | $11.9M | Sell |
362,204
-112,834
| -24% | -$3.72M | 0.03% | 542 |
|
|
2021
Q2 | $30M | Buy |
475,038
+90,307
| +23% | +$5.71M | 0.07% | 304 |
|
|
2021
Q1 | $16.5M | Buy |
384,731
+179,991
| +88% | +$7.72M | 0.04% | 427 |
|
|
2020
Q4 | $11.7M | Sell |
204,740
-106,240
| -34% | -$6.08M | 0.03% | 472 |
|
|
2020
Q3 | $9.38M | Sell |
310,980
-238,558
| -43% | -$7.2M | 0.03% | 433 |
|
|
2020
Q2 | $17.9M | Buy |
549,538
+118,199
| +27% | +$3.86M | 0.09% | 216 |
|
|
2020
Q1 | $11.6M | Buy |
431,339
+214,562
| +99% | +$5.75M | 0.09% | 178 |
|
|
2019
Q4 | $6.64M | Buy |
216,777
+71,464
| +49% | +$2.19M | 0.02% | 642 |
|
|
2019
Q3 | $3.5M | Buy |
+145,313
| New | +$3.5M | 0.01% | 748 |
|